Severe depression as a neuropsychiatric side effect induced by dolutegravir
Authors:
- 26 July 2017
- journal article
- letter
- Published by Wiley in HIV Medicine
- Vol. 19 (4) , e58-e59
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Psychiatric Symptoms in Patients Receiving DolutegravirJAIDS Journal of Acquired Immune Deficiency Syndromes, 2017
- Recent observations on intolerance of dolutegravirAIDS, 2017
- Efficacy and tolerability of dolutegravir and two nucleos(t)ide reverse transcriptase inhibitors in HIV-1-positive, virologically suppressed patientsAIDS, 2017
- Early clinical experience of dolutegravir in an HIV cohort in a larger teaching hospitalInternational Journal of STD & AIDS, 2017
- Intolerance of dolutegravir-containing combination antiretroviral therapy regimens in real-life clinical practiceAIDS, 2016
- Higher rates of neuropsychiatric adverse events leading to dolutegravir discontinuation in women and older patientsHIV Medicine, 2016
- Psychiatric disorders after starting dolutegravirAIDS, 2015
- 48-Week Efficacy and Safety of Dolutegravir Relative to Commonly Used Third Agents in Treatment-Naive HIV-1–Infected Patients: A Systematic Review and Network Meta-AnalysisPLOS ONE, 2014